Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


POLARstar Omega – Multimode Microplate Reader with Fluorescent Polarization

Product Description
polarstar-omega.jpg

The POLARstar Omega is a multimode microplate reader with Tandem Technology and Simultaneous Dual Emission detection for fluorescent polarization. Tandem Technology consists of flexible, highly sensitive filter based detection coupled with ultra-fast UV/Vis spectrometer based absorbance. The proprietary spectrometer can capture full absorbance spectra (220 to 1000 nm) at a resolution of 1 nm and at times faster than 1 second per well.

Simultaneous Dual Emission (SDE) detection makes FP, FRET, and BRET assays faster and more precise because the POLARstar Omega does not have to switch filters or polarizers to read the second channel. Single channel FP microplate readers must read the microplate twice, but the POLARstar Omega collects both emission vectors simultaneously for a fantastic speed advantage.

Applications include:
• Ca2+ measurements (e.g. Ca2+flux with Fura-2, Indo-1, FLUO-3/4)
• Enzyme activity
• FRET/BRET assays
• Cell toxicity, proliferation and viability
• Protein and nucleic acid quantitation (e.g. Bradford, Lowry, DNA, 260/280)
• ATP quantification
• Immunoassays, ELISA
• Luciferase, dual luciferase, BRET with Simultaneous Dual Emission detection, DLReady™ certified
• ORAC and ABEL antioxidant assays
• Fluorescent proteins, including FRETs (e.g. CFP/YFP)
• TR-FRET assays, including HTRF® and LanthaScreen®
• AlphaScreen® Assays
• Transcreener®

POLARstar Omega, the multimode microplate reader for life science laboratories, offers the following detection modes:

• Fluorescence Polarization (FP) / Anisotropy - including Far Red PolarScreen™
• Fluorescence Intensity - including FRET
• Time-Resolved Fluorescence (TRF) - including DELFIA®
• TR-FRET - including HTRF® and LanthaScreen®
• AlphaScreen®
• High-Performance Luminescence (flash and glow) - including BRET
• UV/Vis Absorbance - measurement of complete spectra or individual wavelengths

Additional features
Any POLARstar Omega can have the following features: top and bottom microplate reading, multi-chromatic detection, well scanning, sixteen filter positions, expanded temperature control up to 65°C, plate shaking, gas vent connection, onboard reagent injectors and much more.

Gas Control Capabilities
Using a proprietary Atmospheric Control Unit (ACU), the POLARstar Omega independently controls both the O2 (1-19%) and CO2 (0-20%) gas concentrations within the microplate reader chamber.

Stacker and robot compatibility
For medium level throughput, the POLARstar Omega can be equipped with a 50 plate Stacker with optional bar code reader. For even higher throughput, the POLARstar Omega can be integrated into all existing robotic systems via DDE or ActiveX interface.

Software package
The POLARstar Omega license-free software includes the Omega Reader Control and the MARS Data Analysis software. This highly intuitive software provides limitless possibilities for test set-up and data analysis, while also offering one-click, app-style application shortcuts for running routine tests and data analyses. During the measurement, it is possible to observe the data with the Real Time Graphics feature. While the Standard Curve Wizard creates an easy step-by-step calculation of a standard curve and the Template Manager is an excellent tool for building complex data processing protocols. With MARS, all data analysis is simply done with one click of the mouse.
Product POLARstar Omega – Multimode Microplate Reader with Fluorescent Polarization
Company BMG Labtech GmbH
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BMG Labtech GmbH
Allmendgruen 8, 77799 Ortenberg Germany

Tel: +49 781 96968-0
Fax: +49 781 96968-67
Email: hts@bmglabtech.com



Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!